Results 181 to 190 of about 980,683 (314)

Multiple, Segmental, Non-Syndromic Basal Cell Carcinomas-Clinical, Dermoscopic and Histopathological Features. [PDF]

Diagnostics (Basel)
Sławińska M, Zagórska B, Biernat W, Sobjanek M.   +3 more
europepmc   +1 more source

A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes

, 2003
Timothy J. Ley, Patrick Minx, Matthew J. Walter, Rhonda E. Ries, Hui Sun, Michael D. McLellan, John F. DiPersio, Daniel C. Link, Michael H. Tomasson, Timothy A. Graubert, Howard L. McLeod, H. Jean Khoury, M. A. Watson, William D. Shannon, Kathryn Trinkaus, Sharon E. Heath, James W. Vardiman, Michael A. Caligiuri, Clara D. Bloomfield, Jeffrey Milbrandt, Elaine R. Mardis, Richard K. Wilson   +21 more
openalex   +1 more source

Dendritic‐cell‐based immunotherapy evokes potent anti‐tumor immune responses in CD105+ human renal cancer stem cells [PDF]

, 2017
Xiao‐Fei Zhang, Desheng Weng, Ke Pan, Ziqi Zhou, Qiuzhong Pan, Jingjing Zhao, Yan Tang, Shanshan Jiang, Chang‐Long Chen, Yongqiang Li, Hongxia Zhang, Alfred E. Chang, Max S. Wicha, Yi‐Xin Zeng, Qiao Li, Jian‐Chuan Xia   +15 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Papillary Renal Cell Carcinoma: Analysis of Germline Mutations in the MET Proto-Oncogene in a Clinic-Based Population

, 2001
Noralane M. Lindor, Christopher Dechet, Mark H. Greene, Robert B. Jenkins, M. Tanja Zincke, Amy L. Weaver, Marcia Wilson, Horst Zincke, Wanguo Liu   +8 more
openalex   +1 more source

Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study [PDF]

, 2012
Anneli Ambring, Ingela Björholt, Eva Lesén, Ulrika Stierner, Anders Odén   +4 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Comprehensive Insights Into Basal Cell Carcinoma: Causes, Presentation, Prevention, and Modern Therapeutic Approaches. [PDF]

Cancer Med
Levit S, Shoykhet J, Levit E.
europepmc   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

A Sonidegib Experience in the Treatment of Basal Cell Carcinoma with Systemic Lupus Erythematosus: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Shi L, Liu B, Gao P, Cao X, Wan C.
europepmc   +1 more source